Landry Robert E
SEC Form 4 insider trading activity
Landry Robert E has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Sep 15, 2026.
On the most recent filing, Landry Robert E is listed as Director at CYTOKINETICS INC. Inside the rolling window, Landry Robert E reported no open-market purchases and 2 open-market sales totaling $147K in CYTK. The largest disclosed transaction in the window is a sale of 1,000 CYTK shares on Sep 11, 2026, worth $75K.
Companies traded
Other insiders at CYTK
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$147K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Landry Robert E made?
Landry Robert E has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does Landry Robert E trade?
Landry Robert E has filed SEC Form 4 disclosures for 1 company, including CYTK.
When was Landry Robert E's most recent SEC Form 4 filing?
Landry Robert E's most recent SEC Form 4 filing on Tracefour is dated Sep 15, 2026.
What is Landry Robert E's total buy and sell value in the current window?
Inside the rolling retention window, Landry Robert E bought $0 and sold $147K based on SEC Form 4 filings.
What was Landry Robert E's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,000 CYTK shares on 2026-09-11, worth $75K, per SEC Form 4 filings.